NCT00003464View on ClinicalTrials.gov

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

August 31, 2003

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

temozolomide

RADIATION

radiation therapy

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER